Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)

SIMPLE SUMMARY: We conducted a prospective trial comparing single-dose etoposide (375 mg/m(2) for one day) plus G-CSF versus G-CSF alone, followed by risk-adapted plerixafor in myeloma patients. Despite significantly less frequent (p = 0.045) use of plerixafor in the etoposide group, the optimal col...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sung-Soo, Shin, Seung-Hwan, Lee, Jung-Yeon, Jeon, Young-Woo, Yhang, Seung-Ah, Min, Chang-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572075/
https://www.ncbi.nlm.nih.gov/pubmed/37835477
http://dx.doi.org/10.3390/cancers15194783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572075/
https://www.ncbi.nlm.nih.gov/pubmed/37835477
http://dx.doi.org/10.3390/cancers15194783

Ejemplares similares